SCHEMBL3785256

SCHEMBL3785256

COc1ccc(C(=O)Nc2ccc(Cl)cc2NC(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.77
KMT2A Q03164 6/20 0.75
MEN1 O00255 5/20 0.75
NPSR1 Q6W5P4 3/20 0.75
PKM P14618 1/20 0.75
ALDH1A1 P00352 5/20 0.71
NPC1 O15118 4/20 0.71
RAB9A P51151 4/20 0.71
CYP1A2 P05177 2/20 0.71
CYP3A4 P08684 2/20 0.71
CYP2C9 P11712 2/20 0.71
CYP2C19 P33261 2/20 0.71
HPGD P15428 3/20 0.65
HSD17B10 Q99714 1/20 0.65
MAPT P10636 4/20 0.62
LMNA P02545 2/20 0.62
KDM4E B2RXH2 2/20 0.61
HDAC1 Q13547 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7250878 0.87 F10 (1.00) F10KMT2AMEN1PKMALDH1A1
SCHEMBL1308442 0.86 KMT2A (1.00) F10KMT2AMEN1NPSR1PKM
SCHEMBL7244178 0.86 F10 (0.73) F10KMT2AMEN1NPSR1PKM
SCHEMBL7251219 0.83 F10 (0.79) F10KMT2AMEN1NPSR1ALDH1A1
SCHEMBL7244510 0.83 F10 (0.79) F10KMT2AMEN1ALDH1A1NPC1
SCHEMBL5419665 0.83 F10 (0.74) F10KMT2AMEN1NPSR1PKM
SCHEMBL6351589 0.83 KMT2A (0.75) KMT2AMEN1NPSR1PKMALDH1A1
SCHEMBL23603155 0.82 F10 (0.64) F10KMT2AMEN1NPSR1PKM
SCHEMBL7251068 0.82 NPC1 (0.81) F10KMT2AMEN1PKMALDH1A1
SCHEMBL3783576 0.82 KMT2A (0.60) F10KMT2AMEN1NPSR1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
US-6605626-B2 Benzamide inhibitors of factor Xa ELI LILLY AND COMPANY 2003-08-12 US disclosed
US-20020120007-A1 Benzamide inhibitors of factor Xa BEIGHT DOUGLAS WADE (US) 2002-08-29 US disclosed
US-6313122-B1 AS INHIBITORS OF FACTOR XA AND ARE USED AS ANTICOAGULANTS IN MAMMALS ELI LILLY AND COMPANY 2001-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 F10 1394/4885KMT2A 1474/4885MEN1 174/4885
US-20020120007-A1 Benzamide inhibitors of factor Xa TFPI, F11, F12 F10 12/4885KMT2A 2083/4885MEN1 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.